Clinical Study
Comparison of the Effects of Continuous Subcutaneous Insulin Infusion and Add-On Therapy with Sitagliptin in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
Table 2
Glycemic variability between the CSII and CSII + Sig groups after the suspension of continuous subcutaneous insulin infusion.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Note: MAGE: mean amplitude of glycemic excursions; SDBG: standard deviation of blood glucose; LAGE: largest amplitude of glycemic excursions; MBG: mean blood glucose; PT3.9: proportion (%) of time in hypoglycemia (<3.9 mmol/L); PT10.0: proportion (%) of time in hyperglycemia (>10 mmol/L). Independent-samples -tests were employed. |